NEULAND LABORATORIES LTD. - 524558 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2022
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2022 ,inter alia, to consider and approve The Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2022 NEULAND LABORATORIES LTD. - 524558 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 NEULAND LABORATORIES LTD. - 524558 - Clarification Letter Dated 23/09/2022
Clarification Letter Dated 23/09/2022 NEULAND LABORATORIES LTD. - 524558 - Clarification sought from Neuland Laboratories Ltd
The Exchange has sought clarification from Neuland Laboratories Ltd on September 23, 2022, with reference to Movement in Volume.The reply is awaited. NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Resignation of Chief Financial Officer NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Earnings Call Transcript NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication For Unaudited Financial Results For Q1 FY23 NEULAND LABORATORIES LTD. - 524558 - Audio Recordings Of The Earnings Call Conducted On August 3, 2022
Audio Recordings Of The Earnings Call Conducted On August 3, 2022 NEULAND LABORATORIES LTD. - 524558 - Unaudited Financial Results For The Quarter Ended June 30, 2022, Along With The Press Release And Investor Presentation.
Unaudited Financial Results For The Quarter Ended June 30, 2022, along with the Press Release and Investor Presentation.